The Specialist Pharmacy Service (SPS), the NHS’s leading provider of professional medicines advice, has launched a new online resource hub designed to support healthcare professionals (HCPs) in answering questions about pharmacogenomics (PGx). This comprehensive page brings together a range of guidance, tools, and educational materials to help clinicians navigate the growing field of personalised medicine.
Pharmacogenomics — the study of how a person’s genes affect their response to medicines — is increasingly influencing clinical practice, helping to optimise treatments, minimise adverse effects, and improve patient outcomes. However, as PGx becomes more mainstream, many HCPs face challenges in staying up to date and responding confidently to queries from colleagues and patients.
Recognising this need, the SPS team have developed this resource in collaboration with wider stakeholders. Their expertise in handling real-world PGx questions has shaped the content, ensuring it addresses the most common and complex issues HCPs encounter. The resource hub includes curated links to national guidance, case studies, FAQs, and learning modules, offering practical and trusted information in one easily accessible place.
Jess, who provided input into resource selection, acknowledged the SPS team’s leadership in pushing this forward. “This was very much driven by Christine and Ashley, based on their frontline experience. I was glad to contribute but full credit goes to them for making this happen.”
The page officially launched last week, and is now live on the SPS website. It offers a valuable tool for anyone involved in medicines optimisation, primary care, or personalised care initiatives — from pharmacists and GPs to nurses and commissioners.
Pharmacogenomics: resources to support answering questions – SPS - Specialist Pharmacy Service
For those working in the field, this is a great opportunity to bookmark the page, share it with colleagues, and stay informed as pharmacogenomics becomes an essential part of personalised medicine.